Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About APA?

By Benzinga Insights
May 28, 10:15 AM
APA’s (NYSE:APA) short percent of float has risen 17.28% since its last report. The company recently reported that…

APA

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Peering Into AppLovin’s Recent Short Interest

By Benzinga Insights
May 28, 10:15 AM
AppLovin’s (NYSE:APP) short percent of float has risen 34.4% since its last report. The company recently reported that…

APP

Read More
2 minute read
  • Commodities
  • Earnings
  • Equities
  • Eurozone
  • Intraday Update
  • Markets
  • News
  • Trading Ideas

US Stocks Mixed; Home Prices Increase In March

By Avi Kapoor
May 28, 10:05 AM
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 100 points on Tuesday. Following…

APDN

Read More
2 minute read
  • Cryptocurrency
  • News
  • Top Stories

Millionaire Trader Strikes Again With $3M Profit On Trump-Related MAGA Coin

By Ivan Crnogatić
May 28, 10:01 AM
Anonymous cryptocurrency trader Unipcs, better known as “Bonk Guy,” highlighted his multi-million trading position and the meteoric rise of the Trump-insipred MAGA coin.

$PEPE

Read More
3 minute read
  • Analyst Ratings

Demystifying ATI: Insights From 4 Analyst Reviews

By Benzinga Insights
May 28, 10:01 AM
Analysts’ ratings for ATI (NYSE:ATI) over the last quarter vary from bullish to bearish, as provided by 4…

ATI

Read More
3 minute read
  • Analyst Ratings

17 Analysts Assess Five Below: What You Need To Know

By Benzinga Insights
May 28, 10:01 AM
Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on Five Below…

FIVE

Read More
4 minute read
  • Analyst Ratings

Assessing Fidelity National Info: Insights From 17 Financial Analysts

By Benzinga Insights
May 28, 10:00 AM
Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on Fidelity National…

FIS

Read More
4 minute read
  • Analyst Ratings

3M Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)

By Benzinga Insights
May 28, 10:00 AM
Analysts’ ratings for 3M (NYSE:MMM) over the last quarter vary from bullish to bearish, as provided by 17…

MMM

Read More
4 minute read
  • Analyst Ratings

Beyond The Numbers: 22 Analysts Discuss Texas Roadhouse Stock

By Benzinga Insights
May 28, 10:00 AM
In the last three months, 22 analysts have published ratings on Texas Roadhouse (NASDAQ:TXRH), offering a diverse range…

TXRH

Read More
4 minute read
  • Analyst Ratings

Expert Outlook: Apellis Pharmaceuticals Through The Eyes Of 15 Analysts

By Benzinga Insights
May 28, 10:00 AM
Ratings for Apellis Pharmaceuticals (NASDAQ:APLS) were provided by 15 analysts in the past three months, showcasing a mix…

APLS

Posts pagination

Previous 1 … 571 572 573 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service